Drugs / GLA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01397604 Comparator | Jul 2011 → Mar 2013 | — | Rockefeller University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01397604 ↗ |
| Action | Activate | “a synthetic adjuvant directed to activate TLR4 (GLA)” NCT01397604 ↗ |
| Target | TLR4 | “a synthetic adjuvant directed to activate TLR4 (GLA)” NCT01397604 ↗ |